Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
382
-
Total 13F shares, excl. options
-
51M
-
Shares change
-
-1.39M
-
Total reported value, excl. options
-
$8.87B
-
Value change
-
-$239M
-
Put/Call ratio
-
0.7
-
Number of buys
-
199
-
Number of sells
-
-186
-
Price
-
$173.95
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2015
461 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q2 2015.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 382 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51M shares
.
Largest 10 shareholders include FMR LLC (3.64M shares), VANGUARD GROUP INC (3.18M shares), BlackRock Fund Advisors (2.12M shares), SCOPIA CAPITAL MANAGEMENT LP (2.11M shares), DEUTSCHE BANK AG\ (1.85M shares), STATE STREET CORP (1.58M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (1.55M shares), BlackRock Institutional Trust Company, N.A. (1.51M shares), Palo Alto Investors, LLC (1.44M shares), and BlackRock Advisors LLC (1.43M shares).
This table shows the top 382 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.